Anavasi Diagnostics Receives FDA Emergency Use Authorization for The AscencioDx COVID-19 Test and The AscencioDx Molecular Detector

Anavasi Diagnostics Named as an Honoree in Fast Company's Next Big Things in Tech Awards

Anavasi Diagnostics Announces Newly Elected Outside Board of Directors

Anavasi Diagnostics Announces Appointment of Scott Robitaille As Vice President Of Sales And Marketing

Anavasi Diagnostics Announces New Additions to Leadership Team

New Rapid Molecular COVID-19 Test from Anavasi Diagnostics Awarded $14.9 Million by NIH to Accelerate Test Availability